Skip to main content
. 2020 May 5;2020(5):CD002785. doi: 10.1002/14651858.CD002785.pub2

1. Adverse events.

Study Events in EDTA arm n in EDTA arm Events in placebo arm n in placebo arm
Guldager 1992
Combined events
111 80 74 79
Guldager 1992
Hypocalcaemic symptoms
6 80 2 79
Guldager 1992
Fatigue
12 80 11 79
Guldager 1992
Faintness
11 80 1 79
Guldager 1992
Gastrointestinal symptoms
11 80 7 79
Guldager 1992
Serum‐creatinine increase
7 80 9 79
Guldager 1992
Proteinuria
10 80 4 79
Guldager 1992
Phlebitis at infusion site
35 80 28 79
Guldager 1992
Pain at infusion site
9 80 5 79
Guldager 1992
Headache
7 80 7 79
Guldager 1992
Raynaud's Phenomenon
1 80 0 79
Guldager 1992
Metallic taste
1 80 0 79
Guldager 1992
Dermatitis
1 80 0 79
TACT 2013
Combined events
100 839 127 869

EDTA: ethylene diamine tetra‐acetic acid